Cargando…
Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series Study
Bipolar disorder is a chronic and remitting mental illness. Antidepressants are not effective in treating acute bipolar depression, and antipsychotic drugs used in the treatment of bipolar depression cause frequent side effects. This situation justifies the search for new drugs as well as the repurp...
Autores principales: | Krzystanek, Marek, Pałasz, Artur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589301/ https://www.ncbi.nlm.nih.gov/pubmed/33096753 http://dx.doi.org/10.3390/ph13100326 |
Ejemplares similares
-
Amantadine in Treatment of Dysthymia—The Pilot Case Series Study
por: Krzystanek, Marek, et al.
Publicado: (2023) -
Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study
por: Krzystanek, Marek, et al.
Publicado: (2021) -
Enhancement in Phospholipase D Activity as a New Proposed Molecular Mechanism of Haloperidol-Induced Neurotoxicity
por: Krzystanek, Marek, et al.
Publicado: (2020) -
Possible Antidepressant Effects of Memantine—Systematic Review with a Case Study
por: Krzystanek, Marek, et al.
Publicado: (2021) -
Selected single-nucleotide variants in GRIN1, GRIN2A, and GRIN2B encoding subunits of the NMDA receptor are not biomarkers of schizophrenia resistant to clozapine: exploratory study
por: Krzystanek, Marek, et al.
Publicado: (2020)